CAR-T Competition Heats Up with a New IND Approval – Labiotech.eu (blog)
|
CAR–T Competition Heats Up with a New IND Approval
Labiotech.eu (blog) The FDA has cleared an IND application to Servier to set sail in clinical development of UCART19, an allogeneic CAR–T cell therapy developed by Cellectis. The French company Cellectis is developing off-the-shelf CAR-T therapies for cancer. Hot on the … |
